• milestone pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) - july 2, 2026 marketscreener.com Mon, 06 Jul 2026 14:39:12 GMT
• Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The Manila Times Fri, 03 Jul 2026 01:50:16 GMT
• enterprise value to ebit forward of milestone pharmaceuticals inc. – nasdaq:mist TradingView Wed, 01 Jul 2026 01:22:31 GMT
• Price to sales forward of Milestone Pharmaceuticals Inc. – NASDAQ:MIST TradingView Tue, 30 Jun 2026 19:47:02 GMT
• milestone pharmaceuticals, inc. actuals & estimates (nasdaq:mist) TradingView Fri, 26 Jun 2026 08:12:55 GMT
• milestone pharmaceuticals inc (mist) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 09:21:50 GMT
• milestone pharmaceuticals inc (mist) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 22:20:02 GMT
• milestone pharmaceuticals inc (mist) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 13:38:54 GMT
• milestone pharmaceuticals inc (mist) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 12:12:58 GMT
• milestone pharmaceuticals inc (mist) institutional confidence TradingKey Wed, 17 Jun 2026 11:57:58 GMT
• milestone pharmaceuticals inc (mist) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 11:57:10 GMT
• milestone pharmaceuticals inc (mist) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 11:20:53 GMT
• milestone pharmaceuticals inc (mist) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 11:20:52 GMT
• Milestone Pharmaceuticals (MIST) Climbs Over 5%: Biotech Stock Breaks Above Key Support Zone - Strangle Setup dars.gov.et Wed, 17 Jun 2026 07:00:00 GMT
• milestone pharmaceuticals inc (mist) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• milestone pharmaceuticals inc (mist) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• milestone pharmaceuticals inc (mist) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals (MIST) investors approve equity plan, elect board and ratify PwC Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals Faces Financial Challenges amidst Market Shifts timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT
• milestone pharmaceuticals (mist) holds steady at $1.27 amid low volume and tight range - pcr mean reversion dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals (MIST) director receives 77,000 stock options at $1.22 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals (MIST) awards director 77,000 stock options Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Milestone (NASDAQ: MIST) director receives 77,000 stock options grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals (NASDAQ: MIST) director receives 77,000 stock options grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• director at milestone pharmaceuticals (mist) receives 77,000 stock options at $1.22 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST) Seeking Alpha Tue, 09 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals: Taking The Long View (NASDAQ:MIST) Seeking Alpha Wed, 03 Jun 2026 07:00:00 GMT
• mist technical analysis | trend, signals & chart patterns | milestone pharmaceuticals in (nasdaq:mist) ChartMill Wed, 03 Jun 2026 07:00:00 GMT
• Heart Rhythm Society and Milestone Pharmaceuticals Partner to Expand SVT Patient Education Through UpBeat.org PR Newswire Mon, 01 Jun 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc. Q1 2026 Earnings: Significant EPS Miss as Pre-Revenue Biotech Continues Development - Revenue Growt... dars.gov.et Sun, 31 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: alpha tau medical ltd (drts), neurogene (ngne) and milestone pharmaceuticals (mis... The Globe and Mail Wed, 27 May 2026 18:16:00 GMT
• h.c. wainwright maintains milestone pharmaceuticals(mist.us) with buy rating, maintains target price $8 Moomoo Tue, 26 May 2026 07:00:00 GMT
• mist stock price, quote & chart | milestone pharmaceuticals in (nasdaq:mist) ChartMill Thu, 21 May 2026 07:00:00 GMT
• mist technical analysis | trend, signals & chart patterns | milestone pharmaceuticals in (nasdaq:mist) ChartMill Thu, 21 May 2026 07:00:00 GMT
• supernus pharmaceuticals to make $33.4 million cvr milestone payment Investing.com Thu, 21 May 2026 00:04:40 GMT
• milestone pharmaceuticals’ earnings call signals early momentum TipRanks Wed, 20 May 2026 07:30:04 GMT
• Supernus Pharmaceuticals to make $33.4 million CVR milestone payment Investing.com Wed, 20 May 2026 07:00:00 GMT
• milestone pharmaceuticals shares plunge after cardamyst revenue misses expectations (mist) MSN Tue, 19 May 2026 16:09:39 GMT
• milestone pharmaceuticals (mist) reports q1 loss, lags revenue estimates MSN Sun, 17 May 2026 12:43:40 GMT
• milestone pharmaceuticals shares plunge after cardamyst revenue misses expectations (mist) MSN Sun, 17 May 2026 11:58:21 GMT
• milestone outlines ~2-year phase iii afib-rvr timeline as cardamyst launch reaches ~600 prescriptions MSN Sun, 17 May 2026 07:59:25 GMT
• milestone pharmaceuticals stock (us60041a1025): q1 update and short-interest dynamics in focus AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• milestone pharmaceuticals (mist) reports q1 loss, lags revenue estimates MSN Sat, 16 May 2026 05:46:01 GMT
• milestone pharmaceuticals shares plunge after cardamyst revenue misses expectations (mist) MSN Sat, 16 May 2026 01:41:30 GMT
• milestone outlines ~2-year phase iii afib-rvr timeline as cardamyst launch reaches ~600 prescriptions MSN Fri, 15 May 2026 12:15:18 GMT
• Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc. (NASDAQ:MIST): Is Breakeven Near? simplywall.st Fri, 15 May 2026 07:00:00 GMT
• RTW Investments (MIST) and Roderick Wong disclose 9.99% ownership Stock Titan Fri, 15 May 2026 07:00:00 GMT
• milestone pharmaceuticals (mist) gets a buy from piper sandler The Globe and Mail Fri, 15 May 2026 07:00:00 GMT
• mist maintained by wells fargo -- price target lowered to $7.00 GuruFocus Thu, 14 May 2026 15:34:27 GMT
• milestone pharmaceuticals is maintained at overweight by wells fargo Moomoo Thu, 14 May 2026 14:53:45 GMT
• wells fargo & company issues pessimistic forecast for milestone pharmaceuticals (nasdaq:mist) stock price MarketBeat Thu, 14 May 2026 14:37:26 GMT
• milestone pharmaceuticals inc. - common shares (nq: mist FinancialContent Thu, 14 May 2026 14:22:03 GMT
• milestone pharmaceuticals q1 2026 earnings call: complete transcript Sahm Thu, 14 May 2026 11:57:17 GMT
• Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• nasdaq fireside chat: milestone talks cardiovascular drugs on may 19 Stock Titan Thu, 14 May 2026 07:00:00 GMT
• milestone pharmaceuticals inc. q1 2026 10-q report: financial statements, risk factors, and forward-looking statements – minichart... Minichart Thu, 14 May 2026 07:00:00 GMT
• h.c. wainwright maintains milestone pharmaceuticals(mist.us) with buy rating, maintains target price $8 富途牛牛 Thu, 14 May 2026 07:00:00 GMT
• milestone pharmaceuticals inc. (nasdaq:mist) q1 2026 earnings call transcript Insider Monkey Thu, 14 May 2026 07:00:00 GMT
• milestone pharmaceuticals’ earnings call highlights early launch momentum The Globe and Mail Thu, 14 May 2026 07:00:00 GMT
• piper sandler maintains milestone pharmaceuticals(mist.us) with buy rating, raises target price to $7 Moomoo Thu, 14 May 2026 07:00:00 GMT
• td cowen maintains milestone pharmaceuticals(mist.us) with buy rating, maintains target price $8 Moomoo Thu, 14 May 2026 04:56:55 GMT
• milestone pharmaceuticals inc (mist) q1 2026 earnings call highl GuruFocus Thu, 14 May 2026 01:47:59 GMT
• why milestone pharmaceuticals stock wilted on wednesday sharewise.com Thu, 14 May 2026 01:29:27 GMT
• milestone pharmaceuticals inc. q1 2026 earnings call summary Yahoo Finance Thu, 14 May 2026 00:44:00 GMT
• h.c. wainwright maintains milestone pharmaceuticals(mist.us) with buy rating, maintains target price $8 富途牛牛 Wed, 13 May 2026 22:13:08 GMT
• buy rating reiterated on milestone as cardamyst traction grows and afib program advances; $8 price target unchanged TipRanks Wed, 13 May 2026 21:49:05 GMT
• q1 2026 milestone pharmaceuticals inc earnings call transcript GuruFocus Wed, 13 May 2026 21:10:19 GMT
• milestone pharmaceuticals (nasdaq:mist) issues earnings results MarketBeat Wed, 13 May 2026 20:21:23 GMT
• milestone outlines ~2-year phase iii afib-rvr timeline as cardamyst launch reaches ~600 prescriptions MSN Wed, 13 May 2026 19:23:47 GMT
• milestone pharmaceuticals inc. q1 2026 10-q report: financial statements, risk factors, and forward-looking statements Minichart Wed, 13 May 2026 17:41:00 GMT
• analyst reiterates buy on mist, maintains $8 price target on strong cardamyst launch and expanded afib opportunity TipRanks Wed, 13 May 2026 16:23:08 GMT
• milestone pharmaceuticals (mist) reports strong q1 revenue growt GuruFocus Wed, 13 May 2026 15:44:36 GMT
• milestone pharmaceuticals reports q1 eps (20c), consensus 19c TipRanks Wed, 13 May 2026 13:41:52 GMT
• milestone pharmaceuticals earnings missed by $0.43, revenue fell short of estimates Investing.com South Africa Wed, 13 May 2026 11:51:48 GMT
• milestone pharmaceuticals reports q1 2026: $0.2m product revenue, $26.1m net loss, $184.2m cash TradingView Wed, 13 May 2026 11:33:00 GMT
• milestone pharmaceuticals (nasdaq: mist) posts first cardamyst sales and boosts cash with royalty deal Stock Titan Wed, 13 May 2026 11:04:16 GMT
• Why Milestone Pharmaceuticals Stock Wilted on Wednesday The Motley Fool Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals shares plunge after CARDAMYST revenue misses expectations (MIST) Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc. Q1 2026 Earnings Call Summary Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Reports Progress on CARDAMYST™ Launch and Financial Performance for Q1 2026 Quiver Quantitative Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc. 1Q 2026: Revenue $0.24M, Net loss $26.07M, EPS $(0.20) — 10-Q Summary TradingView Wed, 13 May 2026 07:00:00 GMT
• What date does Milestone Pharmaceuticals's (MIST) report Earnings - Earnings Calendar & Announcement Zacks Investment Research Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc. Stock 12‑Month Price Target Cut to $6.33, Implies 233% Upside TradingView Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals (MIST) Q1 2026 Earnings: EPS and Reven GuruFocus Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc (MIST) Q1 2026 Earnings Call Highl GuruFocus Wed, 13 May 2026 07:00:00 GMT
• Should I buy Milestone Pharmaceuticals (MIST) Zacks Investment Research Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Wed, 13 May 2026 07:00:00 GMT
• Adage (MIST) holds 8,000,000 warrant-derived shares, 6.37% Stock Titan Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Releases Q1 2026 Financial Results AlphaStreet Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals stock tumbles 16% on revenue miss By Investing.com Investing.com Nigeria Wed, 13 May 2026 07:00:00 GMT
• Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update The Manila Times Wed, 13 May 2026 07:00:00 GMT
• milestone pharmaceuticals q1 2026 earnings call: complete transcript Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• heart-rhythm nasal spray fills around 600 scripts as phase 3 starts Stock Titan Wed, 13 May 2026 07:00:00 GMT
• canada's milestone pharmaceuticals q1 revenue misses estimates after cardamyst launch TradingView Wed, 13 May 2026 07:00:00 GMT
• milestone pharmaceuticals (mist) reports q1 loss, lags revenue estimates Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• milestone (nasdaq: mist) posts q1 loss as first cardamyst sales begin Stock Titan Wed, 13 May 2026 07:00:00 GMT
• milestone pharmaceuticals inc - may offer securities up to $300 million - sec filing TradingView Wed, 13 May 2026 07:00:00 GMT
• earnings call transcript: milestone pharmaceuticals q1 2026 misses forecasts, stock drops Investing.com Wed, 13 May 2026 07:00:00 GMT
• milestone pharmaceuticals (nasdaq: mist) files $300m shelf; $100m atm with cantor fitzgerald Stock Titan Wed, 13 May 2026 07:00:00 GMT
• milestone reports q1 results, highlights initial cardamyst sales Benzinga Wed, 13 May 2026 07:00:00 GMT
• according to documents submitted to the u.s. securities and exchange commission (sec), milestone pharmaceuticals inc. may issue an... Bitget Wed, 13 May 2026 06:41:32 GMT
• milestone pharmaceuticals inc expected to post earnings of 31 cents a share - earnings preview TradingView Mon, 11 May 2026 13:51:10 GMT
• milestone submits response to fda complete response letter over cardamyst MSN Mon, 11 May 2026 03:10:16 GMT
• milestone pharmaceuticals to release first quarter 2026 financial results on may 13, 2026 geneonline.com Sun, 10 May 2026 23:21:33 GMT
• milestone pharmaceuticals (nasdaq:mist) upgraded by wall street zen to "hold" rating MarketBeat Sat, 09 May 2026 07:00:00 GMT
• earnings preview: mist to report financial results pre-market on may 13 Moomoo Fri, 08 May 2026 06:58:06 GMT
• Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• biotech milestone pairs may 13 results with investor webcast Stock Titan Wed, 06 May 2026 07:00:00 GMT
• milestone pharmaceuticals gears up for q4 print; here are the recent forecast changes from wall street's most accurate analysts MSN Fri, 01 May 2026 14:38:54 GMT
• [def 14a] milestone pharmaceuticals inc. definitive proxy statement Stock Titan Thu, 30 Apr 2026 20:33:22 GMT
• milestone pharmaceuticals (nasdaq: mist) to vote on equity plan and pay Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• milestone pharmaceuticals inc. (nasdaq:mist) short interest update MarketBeat Thu, 30 Apr 2026 06:44:03 GMT
• mist stock soars pre-market after fda approves first commercial product – retail remains bullish, dismisses 'sell the news' concer... MSN Mon, 27 Apr 2026 17:47:42 GMT
• td cowen maintains milestone pharmaceuticals(mist.us) with buy rating, maintains target price $8 Moomoo Fri, 24 Apr 2026 07:00:00 GMT
• mist technical analysis | trend, signals & chart patterns | milestone pharmaceuticals in (nasdaq:mist) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• milestone pharmaceuticals inc. (nasdaq:mist) receives average rating of "moderate buy" from analysts MarketBeat Fri, 24 Apr 2026 06:28:02 GMT
• mist stock soars pre-market after fda approves first commercial product – retail remains bullish, dismisses 'sell the news' concer... MSN Fri, 24 Apr 2026 04:09:30 GMT
• milestone pharmaceuticals gears up for q4 print; here are the recent forecast changes from wall street's most accurate analysts MSN Fri, 24 Apr 2026 02:11:49 GMT
• milestone (mist) business update | q4 2025: below expectations - block trade Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 01:35:46 GMT
• milestone (mist) business update | q4 2025: below expectations - financial health Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 23:39:41 GMT
• rusan pharma achieves global gmp milestone with pmda japan approval IndiaMedToday Tue, 21 Apr 2026 11:00:00 GMT
• insider sell: joseph oliveto sells 36,500 shares of milestone ph GuruFocus Tue, 21 Apr 2026 01:34:33 GMT
• Insider Sell: Joseph Oliveto Sells 36,500 Shares of Milestone Ph GuruFocus Mon, 20 Apr 2026 07:00:00 GMT
• milestone (mist) ceo sells 36,500 shares under rule 10b5-1 plan Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• joseph oliveto sells 36,500 shares of milestone pharmaceuticals (nasdaq:mist) stock MarketBeat Mon, 20 Apr 2026 07:00:00 GMT
Milestone Pharmaceuticals Inc(NASDAQ:MIST) 
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the Uni...
Website: http://www.milestonepharma.com
Full Time Employees: 28
CEO: Joseph G. Oliveto
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends